D. E. Shaw & Co. Inc. Purchases New Position in Verve Therapeutics, Inc. (NASDAQ:VERV)
D. E. Shaw & Co. Inc. bought a new position in shares of Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) during the fourth quarter, Holdings Channel.com reports. The firm bought 37,984 shares of the company’s stock, valued at approximately $214,000. A number of other hedge funds and other institutional investors have also recently made changes […]
D. E. Shaw & Co. Inc. bought a new position in shares of Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) during the fourth quarter, Holdings Channel.com reports. The firm bought 37,984 shares of the company’s stock, valued at approximately $214,000. A number of other hedge funds and other institutional investors have also recently made changes […]
